Tessa Romero
Stock Analyst at J.P. Morgan
(4.63)
# 854
Out of 4,468 analysts
191
Total ratings
56.2%
Success rate
20.7%
Average return
Main Sectors:
Top Industries:
Stocks Rated by Tessa Romero
| Stock | Action | Price Target | Current | Upside | Ratings | Updated | |
|---|---|---|---|---|---|---|---|
| BHVN Biohaven | Maintained: Buy | n/a | $15.96 | - | 14 | Jun 30, 2026 | |
| LRMR Larimar Therapeutics | Reiterated: Buy | $9 | $3.26 | +176.07% | 2 | Jun 29, 2026 | |
| LXEO Lexeo Therapeutics | Maintained: Buy | $9 | $4.69 | +91.90% | 4 | Jun 25, 2026 | |
| UPB Upstream Bio | Downgraded: Hold | $8 | $7.51 | +6.52% | 10 | Jun 12, 2026 | |
| AGIO Agios Pharmaceuticals | Rated: Hold | $31 | $37.59 | -17.53% | 17 | Jun 11, 2026 | |
| NRIX Nurix Therapeutics | Maintained: Buy | n/a | $23.97 | - | 3 | Jun 11, 2026 | |
| SPTX Seaport Therapeutics | Reiterated: Buy | $42 | $20.57 | +104.18% | 2 | Jun 8, 2026 | |
| CYTK Cytokinetics | Maintained: Buy | $97 | $86.49 | +12.15% | 32 | Jun 5, 2026 | |
| EWTX Edgewise Therapeutics | Rated: Buy | $45 → $53 | $39.56 | +33.97% | 21 | Jun 5, 2026 | |
| OCS Oculis Holding AG | Maintained: Buy | $23 | $14.12 | +62.89% | 4 | Jun 3, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Rated: Buy | $80 → $82 | $60.96 | +34.51% | 15 | May 27, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Sell | n/a | $1.67 | - | 5 | May 26, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Buy | $50 → $56 | $54.88 | +2.04% | 9 | May 8, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Sell | n/a | $3.84 | - | 2 | Apr 2, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Rated: Buy | $38 | $34.00 | +11.76% | 3 | Mar 24, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Hold | $17 → $16 | $23.07 | -30.65% | 13 | Mar 16, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Buy | $26 → $33 | $13.98 | +136.05% | 6 | Mar 10, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Rated: Buy | $31 → $34 | $25.97 | +30.92% | 19 | Mar 4, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Hold | n/a | $3.87 | - | 1 | Nov 18, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Downgraded: Sell | n/a | $7.74 | n/a | 2 | Oct 23, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Hold | n/a | $4.01 | n/a | 4 | Oct 18, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Downgraded: Hold | $22 → $10 | $11.65 | n/a | 2 | Jul 13, 2022 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Downgraded: Hold | n/a | $38.72 | n/a | 1 | Nov 9, 2020 |
Biohaven
Jun 30, 2026
Maintained: Buy
Price Target: n/a
Current: $15.96
Upside: -
Larimar Therapeutics
Jun 29, 2026
Reiterated: Buy
Price Target: $9
Current: $3.26
Upside: +176.07%
Lexeo Therapeutics
Jun 25, 2026
Maintained: Buy
Price Target: $9
Current: $4.69
Upside: +91.90%
Upstream Bio
Jun 12, 2026
Downgraded: Hold
Price Target: $8
Current: $7.51
Upside: +6.52%
Agios Pharmaceuticals
Jun 11, 2026
Rated: Hold
Price Target: $31
Current: $37.59
Upside: -17.53%
Nurix Therapeutics
Jun 11, 2026
Maintained: Buy
Price Target: n/a
Current: $23.97
Upside: -
Seaport Therapeutics
Jun 8, 2026
Reiterated: Buy
Price Target: $42
Current: $20.57
Upside: +104.18%
Cytokinetics
Jun 5, 2026
Maintained: Buy
Price Target: $97
Current: $86.49
Upside: +12.15%
Edgewise Therapeutics
Jun 5, 2026
Rated: Buy
Price Target: $45 → $53
Current: $39.56
Upside: +33.97%
Oculis Holding AG
Jun 3, 2026
Maintained: Buy
Price Target: $23
Current: $14.12
Upside: +62.89%
May 27, 2026
Rated: Buy
Price Target: $80 → $82
Current: $60.96
Upside: +34.51%
May 26, 2026
Maintained: Sell
Price Target: n/a
Current: $1.67
Upside: -
May 8, 2026
Maintained: Buy
Price Target: $50 → $56
Current: $54.88
Upside: +2.04%
Apr 2, 2026
Maintained: Sell
Price Target: n/a
Current: $3.84
Upside: -
Mar 24, 2026
Rated: Buy
Price Target: $38
Current: $34.00
Upside: +11.76%
Mar 16, 2026
Maintained: Hold
Price Target: $17 → $16
Current: $23.07
Upside: -30.65%
Mar 10, 2026
Maintained: Buy
Price Target: $26 → $33
Current: $13.98
Upside: +136.05%
Mar 4, 2026
Rated: Buy
Price Target: $31 → $34
Current: $25.97
Upside: +30.92%
Nov 18, 2025
Maintained: Hold
Price Target: n/a
Current: $3.87
Upside: -
Oct 23, 2024
Downgraded: Sell
Price Target: n/a
Current: $7.74
Upside: n/a
Oct 18, 2024
Maintained: Hold
Price Target: n/a
Current: $4.01
Upside: n/a
Jul 13, 2022
Downgraded: Hold
Price Target: $22 → $10
Current: $11.65
Upside: n/a
Nov 9, 2020
Downgraded: Hold
Price Target: n/a
Current: $38.72
Upside: n/a